Professional Documents
Culture Documents
Drug Interactions
Drug Interactions
Topics covered
• Introduction
1. Pharmacokinetic
2. Pharmacodynamics
DI
Disease Drug
Drugs likely involved in interactions
Precipitating drugs Object Drugs
• Hepatic damage
• Renal failure
• Elderly patients
• Multiple diseases
Nutrient Alteration
excretion in gut flora
Nutrient Nutrient
metabolism absorption
How food can effect drugs
Increase Decrease
• Rifampicin- without food
absorption absorption • Rifabutin- with food
• Rifapentin- no effect of
food
Irritation
of
No effect
digestive
tract
• Tetrcayclines • Erythromycin
• BisacodylMilk • Ketoconazole
Fruit juice
• Iron • celiprolol
supplements • Grapefruit
• Mercaptopurin juice
Swallowing of
the medicine
• Wine-
• iron
Tea/coffee Alcohol
tyramine
absorbtion reaction
• theophylline
Drug Alcohol Interactions
In the absence of alcohol
DI
Pharmaco Pharmaco
Syringe Iv fluids
kinetic dynamic
Interactions outside the body
• Mixing of the drugs in the same syringe
Absorbtion Distribution
Excretion Metabolism
Alter
acidity
Surface Motility
area
Alter P Chelation
gp
Absorbtion
• Chemical Interaction
1. Chelation
Metoclopramide
Increases gastric
emptying
Increases absorbtion of
analgesic in treatment of
acute attack of migraine
Distribution
1. Displacement from tissue binding sites
Distribution
1. Displacement from tissue binding sites
2. Displacement from plasma protein binding
20%
Unbound fraction
Bound fraction
Metabolism
Metabolism
Enzyme Induction
S No. Precipitant drug Object drug
1. Alcohol Warfarin, Phenytoin
2. Barbiturates Chlorpromazine, OCPs, Phenytoin
3. Phenytoin Tolbutamide, OCPs
4. Rifampicin Warfarin, Tolbutamide
5. St. John’s Wort Carbamazepine, SSRIs, Warfarin
Metabolism Metabolism
Enzyme Inhibition
S No. Precipitant Drug Enzyme Object drug
1. Allopurinol Xanthine Oxidase Azathioprine
2. Carbidopa Dopa decarboxylase L-Dopa
3. Disulfiram Aldehyde Alcohol
dehydrogenase
4. MAO Inhibitors Monomine Oxidase Amine containing
foods
Metabolism
Enzyme Inhibition
S.no Precipitant drug Object drug Effect
• Interactions between
1. new drug and existing drug
2. metabolic enzymes (CYP1A2, CYP2B6, CYP3A4)
3. metabolites of the investigational drug
4. Transporter based interactions
Conduct in vitro metabolism and drug
drug interaction studies
+ -
Conduct in vivo studies with specific Label as such based on vitro
substrate studies
appetite
TCA Methylphenidate
Antipsychotics Fenfluramine
Corticosteroids Dexfenfluramine
Sulfonylureas Sibutramine
appetite
Orlistat
Alteration in gut flora
Loss of fat-soluble
vitamins,
Ex. Vit A and E
• Eg.
Anticoagulant drug warfarin and vitamin K
Statins inhibit HMG –CoA Reductase inhibitor – precursor for
cholesterol and coenzyme Q10
Alteration in nutrient excretion
• D- penicillamine & EDTA binds metals Zn2+ and eliminates it via urine
• Diuretics cause loss of ions such as Mg 2+ ,K+ ,Na+ , Ca 2+
Increase duration of action
• Increases duration of
action
• Bloodless field OAT
• Lesser systemic S/E
• Increase
concentration at site
Synergistic Action
Reversal of Toxic Symptoms
Neutralisation of action